Small but global Pharma-GPS is a small pharmaceutical product development consulting firm active in both the US and China, suggesting opportunities to upsell global regulatory strategy, cross-border due diligence, and international licensing support to mid-market pharma/biotech companies.

Strategic partnerships Their In/Out-Licensing platform capability indicates potential sales play around technology scouting, acquisition evaluation, and positioning assets for licensing deals, appealing to CROs, CMOs, and biotech startups seeking monetization pathways.

Regulatory focus With expertise in GLP, GMP, and GCP compliance remediation for Chinese CROs/CMOs, there is a cross-sell opportunity to larger CROs seeking to optimize compliance programs, audits, and regulatory readiness.

Drug development support Their end-to-end drug development strategy and implementation services align with small to mid-sized companies needing risk-based development plans, enabling a sales angle around process optimization, Phase progression, and regulatory strategy.

Tech and security stack The disclosed technology stack and cloud/security tools hint at potential needs for data governance, secure collaboration, and vendor risk management solutions to support global clinical and regulatory work.